Saving Africa’s Future Generations Against Hepatitis B Virus Infection: The Hepatitis B Birth Dose Vaccine

Saving Africa’s Future Generations Against Hepatitis B Virus Infection: The Hepatitis B Birth Dose Vaccine

November 23 2021
08:00 AM
Webinar series
HepB Birth Dose Introduction in African Region

HepB BD Nov 18


To support African countries in the introduction of the hepatitis B birth dose (HepB BD) vaccine into their national vaccination programs, the Coalition for Global Hepatitis Elimination is building a community of practice where stakeholders share experiences and best practices that will facilitate the introduction of the HepB BD vaccine. The HepB BD vaccine is one of the most important strategies for preventing hepatitis B virus (HBV) mother-to-child transmission. However, its coverage in Africa is the lowest globally despite a high prevalence of chronic HBV infection. To support its introduction, the Coalition plans to sensitize healthcare workers on the importance of the HepB BD vaccine, need for timely administration soon after birth and best vaccine delivery strategies to ensure timeliness and increased coverage. The Coalition has partnered with  the sub-Saharan Africa Gastroenterology ECHO clinic which is a regional collaborative model providing medical education and care management that helps clinicians provide expert-level care to patients wherever they live. It uses video-conferencing technology to train, advise, and support primary care providers. Three ECHO training sessions will be held beginning November 23, 2021 at 4:00pm East African time to sensitize healthcare workers on the vaccine.



Time (East Africa time)

4:00-4:05pm       Welcome & introductions | Dr. Hailemichael Desalegn, St. Paul's Hospital Millennium Medical College

4:05-4:15pm        Hepatitis B infection in Africa| Dr. Henry Njuguna, Coalition for Global Hepatitis Elimination (CGHE)

  • Hepatitis B epidemiological burden globally and in Africa
  • Contribution of perinatal transmission to the burden of chronic HBV infection
  • Scale of perinatal HBV prevention in Africa
  • WHO’s universal birth dose vaccine recommendation

4:15-4:35pm  Hepatitis B birth dose vaccine | Dr. Michael Kariuki, Kenyatta National Hospital

  • Immunology
  • Efficacy and effectiveness in preventing HBV mother to child transmission
  • Need for timely administration
  • Heat stability of the vaccine and possibilities for outside cold chain use

4:35-4:50pm  Case presentation | Mulat Nigus (Ethiopia) & Dr. Seadimo Gabakgore and Bonolo Phinius (Botswana)

  • HepB BD pilot vaccination in Ethiopia
  • HepB BD vaccination program in Botswana

4:50-5:00pm       Discussion and wrap up | Dr. John Ward, CGHE


There are no contacts for this webinar.